Tom Pike is Chief Executive Officer of Quintiles and serves on its Board of Directors. In this role, Tom is responsible for driving the company’s growth as the world’s leading provider of biopharmaceutical services. Quintiles delivers services and information that enable its customers to evaluate and demonstrate the safety, efficacy and value of products over the course of their lifecycle. Tom spends much of his time with customers, learning more about the challenges they face and helping them to navigate the complex healthcare environment with greater productivity and predictability.
Tom has concentrated his career in the healthcare and technology industries and he is viewed as a leading expert in the provision of business services within these fields. With 30 years of experience, Tom brings an integrated, patient-centric view of healthcare, spanning pharma, payers, and providers to help customers be successful.
Tom spent 22 years at Accenture, including 15 years in leadership roles, partnering with many of its key clients globally. As managing director of Accenture’s North America Health and Products business areas, he successfully grew the portfolio of businesses. This operating unit included pharmaceutical and medical device firms, payers and providers, and drug retailers and distributors. Previously, he was the global chief operating officer for Accenture’s Resources operating group which included utilities, energy and other highly regulated industries. In both operating units, he partnered with clients on their growth strategies and initiatives, as well as enabling them to deliver significant operational efficiency improvements.
More recently, he was chief risk officer, serving on Accenture’s Executive Committee and a member of the small team of executives who reviewed major company transactions. In this role Tom reported to the Board of Directors on organizational risks, key programs and challenges. Previously Tom also served as Accenture’s chief strategy officer, developing business direction and strategy for both clients and the company. As such, he served on the leadership team that prepared the company for its initial public offering.
Throughout Tom’s career, he has worked with leading companies on issues of strategy, operations and technology. In addition, Tom has consulted with and had teams at multiple pharmaceutical firms off and on since the mid 1990’s. After leaving Accenture Tom worked on a variety of healthcare and business services opportunities with PE firms. Early in his career, he was a consultant at McKinsey & Company, working with clients on strategy development across a range of industries.
He earned his bachelor of science in accounting at the University of Delaware.